Atrash, S
Tullos, A
Panozzo, S
Bhutani, M
Van Rhee, F
Barlogie, B
Usmani, S Z
Article History
First Online: 16 January 2015
Competing interests
: SZU is a consultant to Celgene, Millennium, Onyx and Sanofi. He has received research funding from ArrayBioPharma, Celgene, Onyx, Janssen and Pharmacyclics and speaking honoraria from Celgene, Millennium and Onyx. BB has received research funding from Celgene and Novartis. He is a consultant to Celgene and Genzyme and has received speaking honoraria from Celgene and Millennium. BB is a coinventor on patents and patent applications related to use of gene expression profiling in cancer medicine. The remaining authors declare no conflict of interest.